Liminatus Pharma, Inc（LIMN, LIMNW）美股招股说明书 S-1（2026-06-24首版）（英文版）（166页）.pdf

1、Table of ContentsAs filed with the U.S.Securities and Exchange Commission on June 23,2026.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENTUNDER THE SECURITIES ACT OF 1933LIMINATUS PHARMA,INC.(Exact name of registrant as specified i

2、n its charter)Delaware 6770 93-2710748(State or other jurisdiction ofincorporation)(Primary Standard IndustrialClassification Code Number)(IRS EmployerIdentification Number)2251 Stern Goodman Street,Suite EFullerton,California 92833(213)273-5453(Address,including zip code,and telephone number,includ

3、ing area code,of registrants principal executive offices)Chris KimChief Executive Officer2251 Stern Goodman Street,Suite EFullerton,California 92833(213)273-5453(Name,address including zip code,and telephone number,including area code,of agent for service)With copies to:Mitchell S.NussbaumGiovanni C

4、arusoLoeb&Loeb LLP345 Park AvenueNew York,NY 10154Telephone:(212)407-4000Approximate date of commencement of proposed sale to the public:From time to time after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or

5、continuous basis pursuant to Rule 415 under the Securities Actof 1933,check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following boxand list the Securities Act registration statement numbe

6、r of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list the Securities Actregistration statement number of the earlier effective registration statement fo